PORTFOLIA WOMEN’S HEALTH FUND IV
NOW TAKING RESERVATIONS
Portfolia is the most active investor in women's health in the US, with 60+ investments in fast-growth women’s health companies, from seed stage to pre-IPO. Investments include early-stage companies like Bone Health(osteopenia) and Your Choice (the first male birth control pill) to fast scaling brand-name companies, like unicorns Everly Health and Maven Clinic. The Portfolia Women’s Health Fund IV builds on Portfolia’s global brand in women's health, optimizing returns and enhancing the health and wellness of women globally.
Portfolia raised the world's first venture capital fund focused exclusively in women's health in 2018, and has the most robust pipeline of investment opportunities in the field. We are the experts in scaling women’s health companies, for outsized returns and impact. McKinsey has sized the investment opportunity in women’s health at $1 trillion dollars. Portfolia Funds are best positioned to continue to lead in selecting and growing the innovative companies in women’s health for the world.
“Portfolia is the leading investor in women’s health in the US, with
60+ investments in healthcare companies.”
Using its AI epigenetics platform to detect dysregulation across genes and pioneering a new category of diagnostics for male infertility.
FEMDX is a developer of cancer diagnosis devices designed to detect ovarian cancer.
Simple Health Kit provides high-quality, accessible, and affordable diagnostic services for chronic health conditions.
Neuspera develops ultra-miniaturized, implantable medical devices for treating chronic conditions such as Overactive Bladder (OAB).
Our Focus Areas
Portfolia goes beyond, the obvious investments in menstrual care, fertility solutions and pregnancy care have received the most significant investments, into all facets of women's health and wellness at every stage of life. Portfolia will consider companies in the following areas, but not limited to:
Women-specific Conditions: Contraception, Fertility, Maternal Health, Menopause, Gynecology & Women’s Oncology
Conditions that Affect Women Differently: Cardiovascular Disease, Diabetes, Alzheimer’s Disease
Conditions that Affect Women Disproportionally: Autoimmune Disease, Osteoporosis, Anxiety and Depression, Lung Cancer, Eating Disorders
Conditions Characterized by Gender-based Discrepancies in care: Pain Management, Behavioral Health, Addiction
Racial disparities and inequities in women's health: Conditions that affect women of color differently, access to care, quality of care, lack of culturally competent care providers, systemic racism
FEMTECH COMPANIES IN THE NEWS
WHY INVEST IN FEMTECH NOW?
Traditionally, women’s health investment and research has been woefully underfunded. This is rapidly changing, and Portfolia is leading the way. Less than 2% of federal medical research had been invested in women’s health and until quite recently, women were systematically left out of research protocols. Today an additional $1 Billion has been committed to women’s health research opening up new innovations and opportunities for investment.
Venture capitalists are the ones that ‘greenlight’ and fund the latest healthcare technologies post research, but because women make up only 2% of VC investing partners, women’s health investments were rarely understood or appreciated for potential returns or impact. Portfolia has changed this dynamic, aggregating tens of millions of dollars of women’s investment capital and focusing our dollars and expertise in the growth and success of these companies.
The result is outsized financial returns for women and better health and wellness for ourselves, our children, and generations to come. Investing is where change happens.
Investments in women’s health is a $1 trillion opportunity.
2024 is on pace to become a top three funding year for the women's health sector.
$435M Investments in non-fertility startups in 2023
This single quarter record shows a heartening shift in the long-held misconception that fertility and pregnancy are the sole focus of women’s health.
